Clinical Trial Update: HSV G207 in Children With Recurrent or Refractory Cerebellar Brain Tumors [Phase 1]

View source ↗

Summary

Phase 1 trial updating the investigation of HSV-1 G207 for children with recurrent or refractory cerebellar brain tumors; the study is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Central Nervous System Neoplasms
• Cerebellar Neoplasms
• Glioblastoma Multiforme
• Medulloblastoma
• Primitive Neuroectodermal Tumor of the Cerebellum

Drugs mentioned

• G207 (HSV-1 oncolytic virus) (G207)

Snippet

Sponsor: M.D. Anderson Cancer Center | Conditions: Neoplasms, Brain, Glioblastoma Multiforme | Phase 1 | Status: RECRUITING